These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

395 related items for PubMed ID: 16334202

  • 21. Influence of the assays of endogenous colony formation and serum erythropoietin on the diagnosis of polycythemia vera and essential thrombocythemia.
    Mossuz P, Groupe d'Etudes Multicentriques des Syndrome MyéloProlifératifs (GEMSMP).
    Semin Thromb Hemost; 2006 Apr; 32(3):246-50. PubMed ID: 16673278
    [Abstract] [Full Text] [Related]

  • 22. Polycythaemia and portal vein thrombosis.
    Drénou B, Le Prisé PY, Poilane B, Bernard-Griffiths I, Ghandour C, Fauchet R.
    Nouv Rev Fr Hematol (1978); 1992 Apr; 34(5):399-403. PubMed ID: 1296193
    [Abstract] [Full Text] [Related]

  • 23. [Polycythemia: primary or secondary? The differential diagnostic value of stem cell cultures].
    Küng C, Huxol H, Müller R, Speck B, Nissen C.
    Schweiz Med Wochenschr; 1993 Jan 23; 123(3):53-6. PubMed ID: 8426948
    [Abstract] [Full Text] [Related]

  • 24. [The risk factors for thrombosis, myelofibrosis and leukemia transformation in patients with polycythemia vera].
    Bai J, Xue YP, Ye L, Yao JF, Zhou CL, Qian LS, Yang RC, Li HY, Zhang HY, Shao ZH.
    Zhonghua Xue Ye Xue Za Zhi; 2007 Oct 23; 28(10):685-8. PubMed ID: 18399175
    [Abstract] [Full Text] [Related]

  • 25. Diagnosing polycythemia vera: a paradigm shift.
    Tefferi A.
    Mayo Clin Proc; 1999 Feb 23; 74(2):159-62. PubMed ID: 10069355
    [Abstract] [Full Text] [Related]

  • 26. [Detection for endogenous erythroid colony in the patients with polycythemia vera and its clinical significance].
    Bai J, Shao ZH, Liu H, Shi J, He GS, Cao YR, Cui ZZ, Sun J, Tian Z, Jia HR, Qian LS, Yang TY, Yang CL.
    Zhonghua Xue Ye Xue Za Zhi; 2003 Nov 23; 24(11):561-4. PubMed ID: 14720438
    [Abstract] [Full Text] [Related]

  • 27. [A 53-year-old man with headache and concentration difficulties].
    Vik A, Berntsen R, Isaksen V, Haug E, Hansen JB.
    Tidsskr Nor Laegeforen; 2005 Oct 06; 125(19):2647-9. PubMed ID: 16231451
    [Abstract] [Full Text] [Related]

  • 28. Polycythemia vera and other polycythemic states.
    Landaw SA.
    Clin Lab Med; 1990 Dec 06; 10(4):857-71. PubMed ID: 2272178
    [Abstract] [Full Text] [Related]

  • 29. Risk of leukemic transformation in PV and ET patients.
    Chomienne C, Rain JD, Brière J, French PV and ET Study Groups.
    Pathol Biol (Paris); 2004 Jun 06; 52(5):289-93. PubMed ID: 15217716
    [Abstract] [Full Text] [Related]

  • 30. An inhibitor of Janus kinase 2 prevents polycythemia in mice.
    Mathur A, Mo JR, Kraus M, O'Hare E, Sinclair P, Young J, Zhao S, Wang Y, Kopinja J, Qu X, Reilly J, Walker D, Xu L, Aleksandrowicz D, Marshall G, Scott ML, Kohl NE, Bachman E.
    Biochem Pharmacol; 2009 Aug 15; 78(4):382-9. PubMed ID: 19413997
    [Abstract] [Full Text] [Related]

  • 31. Retinopathy secondary to anemia from myeloid metaplasia in polycythemia vera.
    Blood AM, Lowenthal EA, Nowakowski RW.
    J Am Optom Assoc; 1997 Nov 15; 68(11):734-8. PubMed ID: 9409109
    [Abstract] [Full Text] [Related]

  • 32. Myelofibrosis with myeloid metaplasia: the advanced phase of an untreated disseminated hematological cancer. Time to change our therapeutic attitude with early upfront treatment?
    Hasselbalch HC.
    Leuk Res; 2009 Jan 15; 33(1):11-8. PubMed ID: 18632152
    [Abstract] [Full Text] [Related]

  • 33. Vascular and neoplastic risk in a large cohort of patients with polycythemia vera.
    Marchioli R, Finazzi G, Landolfi R, Kutti J, Gisslinger H, Patrono C, Marilus R, Villegas A, Tognoni G, Barbui T.
    J Clin Oncol; 2005 Apr 01; 23(10):2224-32. PubMed ID: 15710945
    [Abstract] [Full Text] [Related]

  • 34. Erythroid progenitors in polycythemia vera.
    Varet B, Casadevall N, Lacombe C.
    Blood Cells; 1981 Apr 01; 7(1):125-32. PubMed ID: 7187745
    [Abstract] [Full Text] [Related]

  • 35. Radioimmunoassay of immunoreactive erythropoietin as a clinical tool for the classification of polycythaemias.
    Najean Y, Schlageter MH, Toubert ME, Podgorniak MP.
    Nouv Rev Fr Hematol (1978); 1990 Apr 01; 32(4):237-40. PubMed ID: 2290709
    [Abstract] [Full Text] [Related]

  • 36. Polycythemia vera.
    Stuart BJ, Viera AJ.
    Am Fam Physician; 2004 May 01; 69(9):2139-44. PubMed ID: 15152961
    [Abstract] [Full Text] [Related]

  • 37. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A.
    Pathobiology; 2007 May 01; 74(2):97-114. PubMed ID: 17587881
    [Abstract] [Full Text] [Related]

  • 38. [A clinical and biological study of 33 cases of polycythemia vera].
    Corredoira JC, González M, Pérez R, Casariego E, López MJ, García JF, Arias J.
    Rev Clin Esp; 1990 May 01; 186(8):378-82. PubMed ID: 2236766
    [Abstract] [Full Text] [Related]

  • 39. Diagnosis and treatment of thrombocythemia in myeloproliferative disorders.
    Gilbert HS.
    Oncology (Williston Park); 2001 Aug 01; 15(8):989-96, 998; discussion 999-1000,1006,1008. PubMed ID: 11548978
    [Abstract] [Full Text] [Related]

  • 40. [Polycythemia vera].
    Nagy G.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1970 Aug 01; 93(4):381-97. PubMed ID: 4195487
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.